Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019030 · ClinicalTrials.gov registry record
Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
A clinical trial, sponsored by Olympus Corporation of the Americas.
- Terminated
- Registry status
- 5
- Enrollment target
NCT02019030 is a clinical trial that was terminated before completion, run by Olympus Corporation of the Americas. The registered enrollment target is 5 participants.
The verdict
NCT02019030 was terminated before completion, sponsored by Olympus Corporation of the Americas.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this observational study is to evaluate the outcomes of using the PlasmaButton electrode in the treatment on Benign Prostatic Hyperplasia (BPH) while on anticoagulation medication.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-01-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019030
The ClinicalTrials.gov registry entry for NCT02019030 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olympus Corporation of the Americas, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02019030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02019030 about?
NCT02019030 is a clinical study titled "Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode". The purpose of this observational study is to evaluate the outcomes of using the PlasmaButton electrode in the treatment on Benign Prostatic Hyperplasia (BPH) while on anticoagulation medication.
What is the current status of trial NCT02019030?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2013-12. Estimated completion is 2017-01-03.
Who is sponsoring clinical trial NCT02019030?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.